Pathology, Microbiology & Immunology Department, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
BMC Infect Dis. 2009 Nov 24;9:184. doi: 10.1186/1471-2334-9-184.
Shigellosis causes diarrheal disease in humans from both developed and developing countries, and multi-drug resistance is an emerging problem. The objective of this study is to present a unified approach that can be used to characterize endemic and outbreak patterns of shigellosis using use a suite of epidemiologic and molecular techniques. The approach is applied to a California case study example of endemic shigellosis at the population level.
Epidemiologic patterns were evaluated with respect to demographics, multi-drug resistance, antimicrobial resistance genes, plasmid profiles, and pulsed-field gel electrophoresis (PFGE) fingerprints for the 43 Shigella isolates obtained by the Monterey region health departments over the two year period from 2004-2005.
The traditional epidemiologic as well as molecular epidemiologic findings were consistent with endemic as compared to outbreak shigellosis in this population. A steady low level of cases was observed throughout the study period and high diversity was observed among strains. In contrast to most studies in developed countries, the predominant species was Shigella flexneri (51%) followed closely by S. sonnei (49%). Over 95% of Shigella isolates were fully resistant to three or more antimicrobial drug subclasses, and 38% of isolates were resistant to five or more subclasses. More than half of Shigella strains tested carried the tetB, catA, or blaTEM genes for antimicrobial resistance to tetracycline, chloramphenicol, and ampicillin, respectively.
This study shows how epidemiologic patterns at the host and bacterial population levels can be used to investigate endemic as compared to outbreak patterns of shigellosis in a community. Information gathered as part of such investigations will be instrumental in identifying emerging antimicrobial resistance, for developing treatment guidelines appropriate for that community, and to provide baseline data with which to compare outbreak strains in the future.
志贺菌会引起发达国家和发展中国家人类的腹泻病,而且多药耐药性是一个新出现的问题。本研究的目的是提出一种统一的方法,该方法可以使用一系列流行病学和分子技术来描述志贺菌病的地方性和暴发流行模式。该方法应用于加利福尼亚州的一个地方性志贺菌病的案例研究,在人群水平上进行研究。
从 2004 年至 2005 年的两年间,通过蒙特雷地区卫生部门获得了 43 株志贺氏菌分离株,评估了其流行病学模式,包括人口统计学、多药耐药性、抗生素耐药基因、质粒图谱和脉冲场凝胶电泳(PFGE)指纹图谱。
与暴发性志贺菌病相比,该人群的传统流行病学和分子流行病学发现均符合地方性志贺菌病。在整个研究期间,观察到病例呈稳定的低水平,且菌株间具有高度多样性。与大多数发达国家的研究不同,优势菌种为福氏志贺菌(51%),紧随其后的是宋内志贺菌(49%)。超过 95%的志贺氏菌分离株对三种或更多抗生素亚类完全耐药,38%的分离株对五种或更多亚类耐药。超过一半的志贺氏菌菌株携带 tetB、catA 或 blaTEM 基因,分别对四环素、氯霉素和氨苄西林具有抗生素耐药性。
本研究表明,宿主和细菌种群水平的流行病学模式如何可用于调查社区中志贺菌病的地方性和暴发流行模式。此类调查收集的信息对于识别新出现的抗生素耐药性、为该社区制定适当的治疗指南以及为未来比较暴发菌株提供基线数据将非常有帮助。